Elan chairman Robert Ingram. In a statement to the Irish Stock Exchange, Elan said it was “proceeding with a formal sale process”. Photograph: David Sleator

Irish biotech group Elan has put itself on the market after indications that shareholders will reject key elements of its restructuring plan.In a stat(...)

Elan shareholders vote on four proposed investments by the company at an EGM on Monday.Photographer: Dara Mac Dónaill

A High Court judge has granted an injunction effectively keeping alive Royalty Pharma’s $6.7 billion offer for Elan pending the outcome of a full lega(...)

Irish pharma giant Elan will be under the spotlight next month as the company seeks shareholder approval for a number of acquisitions including Aus(...)